.jpg)
.png)
All
Clinical Feature: The PCSK9 Revolution: Hope or Hype? Latest Clinical Trial Results and Implications
.article-image{ display:inline-block; float:left; width: 550px; padding-right:5px; } In the late 1980s and in the 1990s, the emergence of the powerful statin drugs transformed treatment of dyslipidemia. Since then they have become the standard of care for managing this condition. Not since... more
th, td { padding: 3px; } .field-name-field-rating, .field-name-field-publish-date, .statistics_counter { display: none!important; } This special award is to be granted in the following manner: Criteria Nominees for this award shall be clinicians and/or... more
Following a June 2015 recommendation by the U.S Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, the FDA has approved evolocumab for use in addition to diet and maximally-tolerated statin therapy in adult patients with heterozygous familial... more
During this year’s Annual Sessions in Las Vegas, use the #NLAVegas hashtag to follow updates from the NLA and your colleagues. Here you can find session info and locations, as well as behind-the-scenes photos and more
I'm happy to give you an update on an important initiative the NLA and its partners are pursuing to kick off 2014. Just more than a month ago the National Lipid Association submitted a proposal to the National Center for Health Statistics (NCHS), the federal agency responsible for revising the... more
This joint expert review by the Obesity Medicine Association (OMA) and National Lipid Association (NLA) provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk. Among individuals with obesity,... more
It is my privilege to proudly present this edition of LipidSpin from the Southwest Chapter of the National Lipid Association (SWLA). This chapter includes the states of Arizona, Colorado, New Mexico, Texas, Louisiana, Oklahoma, and Wyoming. This edition will address some new topics not covered... more
The National Lipid Association has featured highlights from selected presentations at the 2015 Spring Clinical Lipid Update in Denver. Read our meeting coverage here.
th, td { padding: 3px; } .field-name-field-rating, .field-name-field-publish-date, .statistics_counter { display: none!important; } This special award is to be granted in the following manner: Criteria Nominees for this award must support the mission of... more
NLA President Antonio M. Gotto, MD, DPhil, FNLA, today announced the launch of an NLA Membership Recruitment Campaign at the opening session of the organization’s Fall CLU.